As COVID-19 cases become more prevalent in the general population, you may need to understand the available treatments. From a public health perspective, prevention is preferred over treatment so it is still important to continue masking, maintaining distance from others, … Continue reading COVID-19 treatments: antivirals or antibodies?
As you may have heard, Biden recently approved at-home tests for households delivered by USPS. As we increasingly face COVID-19 testing situations, we will talk about which test is appropriate for when and what it tells you. The PCR test … Continue reading COVID-19 testing: PCR or rapid?
The impacts on health in early life cumulatively influences the next stages all the way through old age. The life course model allows us to visualize new life choices within the context of COVID-19 (summary table at the bottom). Fetal/Infant … Continue reading Visualizing new life choices within the context of the COVID-19 pandemic
Updated on April 27th, 2021 with summary table on how common COVID-19 vaccine concerns are addressed and their sources at the bottom. By Michelle Rufrano & Jean-Ezra Yeung Executive Summary Multiple COVID-19 vaccine surveys show that the plan to get … Continue reading Under-represented groups are rightfully nervous about getting the COVID-19 vaccine
Executive Summary The UK, South African and Brazilian variants are of concern because of increased prevalence and they carry mutation(s) such that vaccine and antibody therapies have shown less neutralizing activity in the lab Early Novavax clinical trial findings showed … Continue reading When does a COVID-19 variant become a concern (for you)?